Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Nature Biotechnology (2007) 25, (1256-1264))

Russell P. Rother; Scott A. Rollins; Christopher F. Mojcik; Robert A. Brodsky; Leonard Bell

doi:10.1038/nbt1207-1488c

Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Nature Biotechnology (2007) 25, (1256-1264))

Russell P. Rother, Scott A. Rollins, Christopher F. Mojcik, Robert A. Brodsky, Leonard Bell

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1488
Number of pages	1
Journal	Nature biotechnology
Volume	25
Issue number	12
DOIs	https://doi.org/10.1038/nbt1207-1488c
State	Published - Dec 2007
Externally published	Yes

ASJC Scopus subject areas

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Molecular Medicine
Biomedical Engineering

Access to Document

10.1038/nbt1207-1488c

Cite this

Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Nature Biotechnology (2007) 25, (1256-1264)). / Rother, Russell P.; Rollins, Scott A.; Mojcik, Christopher F. et al.
In: Nature biotechnology, Vol. 25, No. 12, 12.2007, p. 1488.

Research output: Contribution to journal › Comment/debate › peer-review

@article{614775ccc67e4e41b3cbca729d9ddd9d,

title = "Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Nature Biotechnology (2007) 25, (1256-1264))",

author = "Rother, {Russell P.} and Rollins, {Scott A.} and Mojcik, {Christopher F.} and Brodsky, {Robert A.} and Leonard Bell",

year = "2007",

month = dec,

doi = "10.1038/nbt1207-1488c",

language = "English (US)",

volume = "25",

pages = "1488",

journal = "Nature biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Erratum

T2 - Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Nature Biotechnology (2007) 25, (1256-1264))

AU - Rother, Russell P.

AU - Rollins, Scott A.

AU - Mojcik, Christopher F.

AU - Brodsky, Robert A.

AU - Bell, Leonard

PY - 2007/12

Y1 - 2007/12

UR - http://www.scopus.com/inward/record.url?scp=36849006481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36849006481&partnerID=8YFLogxK

U2 - 10.1038/nbt1207-1488c

DO - 10.1038/nbt1207-1488c

M3 - Comment/debate

AN - SCOPUS:36849006481

SN - 1087-0156

VL - 25

SP - 1488

JO - Nature biotechnology

JF - Nature biotechnology

IS - 12

ER -

Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Nature Biotechnology (2007) 25, (1256-1264))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this